Track Anteris Technologies Global Corp. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Anteris Technologies Global Corp. Common Stock AVR · Stock Open Anteris Technologies Global Corp. Common Stock in new tab

6.12 USD
EPS
-1.95
P/B
2.44
ROE
-74.65
Beta
0.73
Target Price
14.00 USD
Loading chart...
Key Metrics
Earnings dateNov. 11, 2026
EPS-1.95
Book Value2.58
Price to Book2.44
Debt/Equity1.32
% Insiders16.476%
Growth
Revenue Growth0.63%
Estimates
Forward P/E-5.47
Forward EPS-1.15
Target Mean Price14.00

DCF valuation

Model fair value for Anteris Technologies Global Corp. Common Stock (AVR)
Result
Sign in to run the valuation for AVR.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
4 analysts · consensus Strong buy · mean target 14.00 USD (low 10.00, high 16.00) · as of 1 Nov 2026
Low 10.00
Mean 14.00
High 16.00
Price 6.12
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Anteris Technologies Global Corp. Common Stock Logo Anteris Technologies Global Corp. Common Stock Analysis (AVR)

USA Official Website Stock

Is Anteris Technologies Global Corp. Common Stock a good investment? Anteris Technologies Global Corp. Common Stock (AVR) is currently trading at 6.12 USD. Market analysts have a consensus price target of 14.00 USD. This suggests a potential upside from current levels.

Earnings Schedule: Anteris Technologies Global Corp. Common Stock is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is -1.15.

Investor FAQ

Does Anteris Technologies Global Corp. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Anteris Technologies Global Corp. Common Stock?

Anteris Technologies Global Corp. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of -1.95.

Company Profile

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Exchange Ticker
US AVR
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion